Skip to main content
Account

Peer review reports

From: Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: a case report

Original Submission
10 Apr 2019 Submitted Original manuscript
23 Jun 2019 Reviewed Reviewer Report - Kentaro Fukunaga
17 Jul 2019 Reviewed Reviewer Report - Guilherme Jorge Costa
21 Jul 2019 Author responded Author comments - Hideaki Yamakawa
Resubmission - Version 2
21 Jul 2019 Submitted Manuscript version 2
29 Jul 2019 Reviewed Reviewer Report - Guilherme Jorge Costa
2 Aug 2019 Reviewed Reviewer Report - Kentaro Fukunaga
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
15 Aug 2019 Editorially accepted
22 Aug 2019 Article published 10.1186/s12890-019-0920-9

Learn about peer review

Back to article page

Navigation